Screener
Halozyme Therapeutics HALO PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Computer and office equipment | 6,965 | 8,034 |
| Internal-use software | 2,559 | 1,878 |
| Leasehold improvements | 7,521 | 7,521 |
| Subtotal | 83,700 | 77,601 |
| Accumulated depreciation and amortization | (33,936) | (33,159) |
| Subtotal | 49,764 | 44,442 |
| Right of use of assets | 34,507 | 37,695 |
| Total property and equipment, net | $84,271 | $82,137 |
Item 1. Financial Statements
FAQ
- What is Halozyme Therapeutics's PP&E (net)?
- Halozyme Therapeutics (HALO) reported PP&E (net) of $49.76M in Q2 2026.
- How has Halozyme Therapeutics's PP&E (net) changed year-over-year?
- Halozyme Therapeutics's PP&E (net) increased by 25.7% year-over-year, from $39.6M to $49.76M.
- What is the long-term trend for Halozyme Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's PP&E (net) has grown at a 43.5% compound annual growth rate (CAGR), from $7.29M to $44.44M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Halozyme Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude